$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

$amn Overview Financials Valuation SEC Filings Company Website

2021 Q4 Form 10-K Financial Statement

#000114275022000010 Filed on February 24, 2022

Income Statement

Concept	2021 Q4	2021	2020 Q4
Revenue	$1.363B	$3.984B	$631.3M
YoY Change	115.92%	66.45%	7.56%
Cost Of Revenue	$928.7M	$2.675B	$423.7M
YoY Change	119.19%	66.96%	8.7%
Gross Profit	$434.3M	$1.310B	$207.5M
YoY Change	109.27%	65.4%	5.28%
Gross Profit Margin	31.86%	32.87%	32.88%
Selling, General & Admin	$224.2M	$730.5M	$124.2M
YoY Change	80.5%	32.87%	-6.76%
% of Gross Profit	51.62%	55.78%	59.84%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$27.83M	$103.7M	$24.10M
YoY Change	15.46%	10.1%	41.76%
% of Gross Profit	6.41%	7.92%	11.61%
Operating Expenses	$251.2M	$831.6M	$147.9M
YoY Change	69.87%	29.43%	-1.47%
Operating Profit	$183.1M	$478.0M	$59.64M
YoY Change	207.0%	220.23%	26.8%
Interest Expense	-$9.799M	$34.08M	-$22.70M
YoY Change	-56.83%	-40.98%	155.06%
% of Operating Profit	-5.35%	7.13%	-38.06%
Other Income/Expense, Net	-$27.31M	-$28.84M	-$16.10M
YoY Change	69.61%	-22.23%	-47.23%
Pretax Income	$158.8M	$443.9M	$6.000M
YoY Change	2546.57%	385.04%	-84.25%
Income Tax	$42.58M	$116.5M	-$3.300M
% Of Pretax Income	26.81%	26.25%	-55.0%
Net Earnings	$116.2M	$327.4M	$9.308M
YoY Change	1148.57%	363.3%	-66.13%
Net Earnings / Revenue	8.53%	8.22%	1.47%
Basic Earnings Per Share		$6.87	$0.20
Diluted Earnings Per Share	$2.415M	$6.81	$0.19
COMMON SHARES
Basic Shares Outstanding	47.28M shares	47.69M shares	47.03M shares
Diluted Shares Outstanding		48.05M shares

Balance Sheet

Concept	2021 Q4	2021	2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$180.9M	$180.9M	$29.20M
YoY Change	519.62%	519.62%	-64.82%
Cash & Equivalents	$180.9M	$180.9M	$29.21M
Short-Term Investments	$955.3M	$955.3M	$868.0M
Other Short-Term Assets	$66.83M	$139.3M	$40.81M
YoY Change	63.76%	191.4%	0.9%
Inventory	$3.480B	$3.480B	$3.382B
Prepaid Expenses	$72.46M		$13.63M
Receivables	$789.1M	$1.029B	$376.1M
Other Receivables	$0.00	$0.00	$6.600M
Total Short-Term Assets	$1.349B	$1.349B	$533.7M
YoY Change	152.76%	152.78%	-4.78%
LONG-TERM ASSETS
Property, Plant & Equipment	$127.1M	$154.9M	$116.2M
YoY Change	9.42%	-20.12%	10.82%
Goodwill	$892.3M		$864.5M
YoY Change	3.22%		45.16%
Intangibles	$514.5M		$564.9M
YoY Change	-8.93%		41.77%
Long-Term Investments	$2.287B	$2.248B	$1.944B
YoY Change	17.64%	19.28%	-5.14%
Other Assets	$156.7M	$221.2M	$135.1M
YoY Change	15.95%	12.55%	12.36%
Total Long-Term Assets	$1.783B	$1.783B	$1.820B
YoY Change	-2.03%	-2.03%	32.72%
TOTAL ASSETS
Total Short-Term Assets	$1.349B	$1.349B	$533.7M
Total Long-Term Assets	$1.783B	$1.783B	$1.820B
Total Assets	$3.132B	$3.132B	$2.354B
YoY Change	33.07%	33.07%	21.84%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$425.3M	$77.33M	$167.9M
YoY Change	153.31%	175.18%	7.52%
Accrued Expenses	$61.22M	$427.0M	$37.85M
YoY Change	61.75%	60.34%	4.14%
Deferred Revenue	$15.95M		$11.00M
YoY Change	44.95%		-6.65%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$0.00	$0.00	$4.688M
YoY Change	-100.0%	-100.0%
Total Short-Term Liabilities	$969.4M	$969.4M	$423.0M
YoY Change	129.19%	129.17%	11.86%
LONG-TERM LIABILITIES
Long-Term Debt	$842.3M	$842.3M	$858.0M
YoY Change	-1.83%	-1.83%	39.01%
Other Long-Term Liabilities	$96.99M	$110.4M	$107.9M
YoY Change	-10.12%	-40.57%	74.57%
Total Long-Term Liabilities	$96.99M	$952.7M	$107.9M
YoY Change	-10.12%	-8.72%	74.57%
TOTAL LIABILITIES
Total Short-Term Liabilities	$969.4M	$969.4M	$423.0M
Total Long-Term Liabilities	$96.99M	$952.7M	$107.9M
Total Liabilities	$1.970B	$1.970B	$1.534B
YoY Change	28.43%	28.43%	28.36%
SHAREHOLDERS EQUITY
Retained Earnings	$796.9M		$469.6M
YoY Change	69.72%		17.38%
Common Stock	$498.0K		$496.0K
YoY Change	0.4%		0.61%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$121.8M		$119.1M
YoY Change	2.26%		0.0%
Treasury Stock Shares	2.586M shares		2.561M shares
Shareholders Equity	$1.162B	$1.162B	$819.7M
YoY Change
Total Liabilities & Shareholders Equity	$3.132B	$3.132B	$2.354B
YoY Change	33.07%	33.07%	21.84%

Cashflow Statement

Concept	2021 Q4	2021	2020 Q4
OPERATING ACTIVITIES
Net Income	$116.2M	$327.4M	$9.308M
YoY Change	1148.57%	363.3%	-66.13%
Depreciation, Depletion And Amortization	$27.83M	$103.7M	$24.10M
YoY Change	15.46%	10.1%	41.76%
Cash From Operating Activities	$77.98M	$305.4M	$39.80M
YoY Change	95.94%	18.9%	-49.43%
INVESTING ACTIVITIES
Capital Expenditures	-$14.86M	$53.57M	-$10.30M
YoY Change	44.3%	42.1%	-2.83%
Acquisitions		$41.26M
YoY Change		-91.34%
Other Investing Activities	-$13.52M	-$53.74M	$600.0K
YoY Change	-2353.67%	-89.23%	-102.17%
Cash From Investing Activities	-$28.39M	-$107.4M	-$9.700M
YoY Change	192.63%	-80.04%	-74.61%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$2.688M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-3.665M	-$34.90M	-55.10M
YoY Change	-93.35%	-116.5%	-27650.0%
NET CHANGE
Cash From Operating Activities	77.98M	$305.4M	39.80M
Cash From Investing Activities	-28.39M	-$107.4M	-9.700M
Cash From Financing Activities	-3.665M	-$34.90M	-55.10M
Net Change In Cash	45.93M	$162.7M	-25.00M
YoY Change	-283.74%	-332.56%	-161.43%
FREE CASH FLOW
Cash From Operating Activities	$77.98M	$305.4M	$39.80M
Capital Expenditures	-$14.86M	$53.57M	-$10.30M
Free Cash Flow	$92.85M	$251.8M	$50.10M
YoY Change	85.33%	14.9%	-43.9%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001142750
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2019	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201613Member
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-12-31
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Entity File Number EntityFileNumber	001-16753
CY2021	dei	Entity Registrant Name EntityRegistrantName	AMN HEALTHCARE SERVICES, INC.
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	06-1500476
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	8840 Cypress Waters Boulevard
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 300
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75019
CY2021	dei	City Area Code CityAreaCode	866
CY2021	dei	Local Phone Number LocalPhoneNumber	871-8519
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.01 par value
CY2021	dei	Trading Symbol TradingSymbol	AMN
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q2	dei	Entity Public Float EntityPublicFloat	4564150873	USD
CY2022Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	46641300	shares
CY2021	dei	Auditor Name AuditorName	KPMG LLP
CY2021	dei	Auditor Location AuditorLocation	San Diego, California
CY2021	dei	Auditor Firm AuditorFirmId	185
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180928000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29213000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6838000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7043000	USD
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	789131000	USD
CY2020Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	376099000	USD
CY2021Q4	amn	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	239719000	USD
CY2020Q4	amn	Accountsreceivablesubcontractor Accountsreceivablesubcontractor	73985000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	72460000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13629000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	66830000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40809000	USD
CY2021Q4	us-gaap	Assets Current AssetsCurrent	1349068000	USD
CY2020Q4	us-gaap	Assets Current AssetsCurrent	533735000	USD
CY2021Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	64482000	USD
CY2020Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	61347000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	189954000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	161752000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	127114000	USD
CY2020Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	77735000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116174000	USD
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27771000	USD
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	156670000	USD
CY2020Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	135120000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	892341000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	864485000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	278249000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	215234000	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	514460000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	564911000	USD
CY2021Q4	us-gaap	Assets Assets	3131906000	USD
CY2020Q4	us-gaap	Assets Assets	2353507000	USD
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	425257000	USD
CY2020Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	167881000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	354381000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	213414000	USD
CY2021Q4	us-gaap	Notes Payable Current NotesPayableCurrent	0	USD
CY2020Q4	us-gaap	Notes Payable Current NotesPayableCurrent	4688000	USD
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	11383000	USD
CY2020Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	15032000	USD
CY2021Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	15950000	USD
CY2020Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11004000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	162419000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10938000	USD
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	969390000	USD
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	422957000	USD
CY2021Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	842322000	USD
CY2020Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	857961000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	47814000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	67205000	USD
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	13364000	USD
CY2020Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	77800000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	96989000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107907000	USD
CY2021Q4	us-gaap	Liabilities Liabilities	1969879000	USD
CY2020Q4	us-gaap	Liabilities Liabilities	1533830000	USD
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2020Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	200000000	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49849000	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47263000	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49614000	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47053000	shares
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	498000	USD
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	496000	USD
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	486709000	USD
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	468726000	USD
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2586000	shares
CY2020Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	2561000	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	121831000	USD
CY2020Q4	us-gaap	Treasury Stock Value TreasuryStockValue	119143000	USD
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	796946000	USD
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	469558000	USD
CY2021Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-295000	USD
CY2020Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	40000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1162027000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	819677000	USD
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3131906000	USD
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	2353507000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3984235000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2393714000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2222107000	USD
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2674634000	USD
CY2020	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1601936000	USD
CY2019	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	1478642000	USD
CY2021	us-gaap	Gross Profit GrossProfit	1309601000	USD
CY2020	us-gaap	Gross Profit GrossProfit	791778000	USD
CY2019	us-gaap	Gross Profit GrossProfit	743465000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	730451000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	549747000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	508030000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101152000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	92766000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58520000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	831603000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	642513000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	566550000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	477998000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	149265000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	176915000	USD
CY2021	us-gaap	Interest Expense InterestExpense	34077000	USD
CY2020	us-gaap	Interest Expense InterestExpense	57742000	USD
CY2019	us-gaap	Interest Expense InterestExpense	28427000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	443921000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	91523000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	148488000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	116533000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20858000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34500000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	327388000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	327388000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	70665000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	70665000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	113988000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	113988000	USD
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-335000	USD
CY2020	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-112000	USD
CY2019	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	1000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-335000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-112000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	1000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	327053000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	70553000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	113989000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.87
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.81
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.40
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47685000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47424000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46704000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48045000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47690000	shares
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	638990000	USD
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	18705000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-13773000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	16241000	USD
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47593000	shares
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	113989000	USD
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	736742000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-6929000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	20465000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	70553000	USD
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	819677000	USD
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2688000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	-7232000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	25217000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	327053000	USD
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	1162027000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	327388000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	58520000	USD
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	4067000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	70665000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	113988000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	103697000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	94187000	USD
CY2020	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-4349000	USD
CY2019	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1984000	USD
CY2021	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-158000	USD
CY2020	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-4956000	USD
CY2019	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-594000	USD
CY2021	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	USD
CY2020	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	4900000	USD
CY2019	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	7178000	USD
CY2021	amn	Accounts Receivable Credit Loss Expense Reversal And Sales Credits AccountsReceivableCreditLossExpenseReversalAndSalesCredits	6263000	USD
CY2020	amn	Accounts Receivable Credit Loss Expense Reversal And Sales Credits AccountsReceivableCreditLossExpenseReversalAndSalesCredits	6535000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	20465000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	16241000	USD
CY2021	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	-20000	USD
CY2019	amn	Accounts Receivable Credit Loss Expense Reversal And Sales Credits AccountsReceivableCreditLossExpenseReversalAndSalesCredits	6275000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16287000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21628000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	913000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25217000	USD
CY2020	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	-1646000	USD
CY2019	amn	Gain Loss On Deferred Compensation GainLossOnDeferredCompensation	0	USD
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-2707000	USD
CY2020	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-4322000	USD
CY2019	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-484000	USD
CY2021	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	52000	USD
CY2020	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	109000	USD
CY2019	us-gaap	Investment Income Amortization Of Discount InvestmentIncomeAmortizationOfDiscount	298000	USD
CY2021	amn	Lessee Operating Lease Noncash Expense Benefit LesseeOperatingLeaseNoncashExpenseBenefit	3806000	USD
CY2019	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	22571000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	-6591000	USD
CY2020	amn	Lessee Operating Lease Noncash Expense Benefit LesseeOperatingLeaseNoncashExpenseBenefit	-589000	USD
CY2019	amn	Lessee Operating Lease Noncash Expense Benefit LesseeOperatingLeaseNoncashExpenseBenefit	5000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	419533000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	7338000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-28278000	USD
CY2021	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	165734000	USD
CY2020	amn	Increase Decreasein Accounts Receivablessubcontractor IncreaseDecreaseinAccountsReceivablessubcontractor	1271000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	412000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Receivable IncreaseDecreaseInIncomeTaxesReceivable	4464000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	58788000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1342000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-774000	USD
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	21999000	USD
CY2020	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2322000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	5562000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1925000	USD
CY2019	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-2847000	USD
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3262000	USD
CY2020	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-3220000	USD
CY2019	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	12751000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	256118000	USD
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	129235000	USD
CY2020	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	25856000	USD
CY2019	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	32758000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	122685000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	41640000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-6090000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4320000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1119000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-1806000	USD
CY2021	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-349000	USD
CY2020	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-9000	USD
CY2019	us-gaap	Increase Decrease In Restricted Cash And Investments For Operating Activities IncreaseDecreaseInRestrictedCashAndInvestmentsForOperatingActivities	-78000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	305356000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	256826000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	224862000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	53573000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	37702000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	35218000	USD
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	60719000	USD
CY2020	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	48311000	USD
CY2019	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	26309000	USD
CY2021	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	57660000	USD
CY2020	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	32800000	USD
CY2019	us-gaap	Proceeds From Sale Maturity And Collections Of Investments ProceedsFromSaleMaturityAndCollectionsOfInvestments	32135000	USD
CY2021	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	500000	USD
CY2019	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	779000	USD
CY2020	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2019	us-gaap	Payments To Acquire Equity Method Investments PaymentsToAcquireEquityMethodInvestments	0	USD
CY2021	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	78000	USD
CY2020	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	527000	USD
CY2019	us-gaap	Proceeds From Sale Of Equity Method Investments ProceedsFromSaleOfEquityMethodInvestments	0	USD
CY2021	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	0	USD
CY2020	us-gaap	Payments To Acquire Notes Receivable PaymentsToAcquireNotesReceivable	490000	USD
CY2021	amn	Payments To Fund Deferred Compensation Plan PaymentsToFundDeferredCompensationPlan	7565000	USD
CY2020	amn	Payments To Fund Deferred Compensation Plan PaymentsToFundDeferredCompensationPlan	7171000	USD
CY2019	amn	Payments To Fund Deferred Compensation Plan PaymentsToFundDeferredCompensationPlan	12507000	USD
CY2021	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	1429000	USD
CY2020	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	0	USD
CY2019	us-gaap	Payments For Leasing Costs PaymentsForLeasingCosts	0	USD
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	41264000	USD
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	476491000	USD
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	247906000	USD
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	90000	USD
CY2020	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1400000	USD
CY2019	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	1240000	USD
CY2021	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	USD
CY2020	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	66000	USD
CY2019	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	0	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-107402000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-538172000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-291824000	USD
CY2021	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	21875000	USD
CY2020	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	228125000	USD
CY2019	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	150000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	250000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Secured Debt ProceedsFromIssuanceOfSecuredDebt	150000000	USD
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	70000000	USD
CY2020	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	245000000	USD
CY2019	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	221000000	USD
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	70000000	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	245000000	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	101000000	USD
CY2021	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	552000000	USD
CY2019	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	300000000	USD
CY2021	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2020	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	333330000	USD
CY2019	us-gaap	Repayments Of Senior Debt RepaymentsOfSeniorDebt	0	USD
CY2021	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2688000	USD
CY2020	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
CY2019	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	18705000	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	11508000	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	5223000	USD
CY2021	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	3100000	USD
CY2020	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	10622000	USD
CY2019	amn	Payments For Previous Acquisition Earn Out Payment PaymentsForPreviousAcquisitionEarnOutPayment	5700000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	7232000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	6929000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	13773000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34895000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	211486000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	136599000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-335000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-112000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	162724000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-69972000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	69638000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83990000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153962000	USD
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	84324000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246714000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83990000	USD
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	153962000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	39865000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	20052000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	17817000	USD
CY2021	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	349000	USD
CY2020	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	389000	USD
CY2019	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	536000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	38085000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	22652000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	23730000	USD
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	106379000	USD
CY2020	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	46258000	USD
CY2019	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	37747000	USD
CY2021	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	1906000	USD
CY2020	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	35733000	USD
CY2019	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	29660000	USD
CY2021	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	27193000	USD
CY2020	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	268971000	USD
CY2019	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Goodwill SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesGoodwill	157036000	USD
CY2021	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	12440000	USD
CY2020	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	228000000	USD
CY2019	amn	Supplemental Disclosures Of Non Cash Investing And Financing Activities Intangible Assets SupplementalDisclosuresOfNonCashInvestingAndFinancingActivitiesIntangibleAssets	107580000	USD
CY2021	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	275000	USD
CY2020	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	56213000	USD
CY2019	us-gaap	Liabilities Assumed1 LiabilitiesAssumed1	31148000	USD
CY2021	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	0	USD
CY2020	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	0	USD
CY2019	amn	Noncash Or Part Noncash Acquisition Earn Out Liability NoncashOrPartNoncashAcquisitionEarnOutLiability	15222000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	41264000	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	476491000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	247906000	USD
CY2021	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	3719000	USD
CY2020	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	3103000	USD
CY2019	amn	Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses Purchaseoffixedassetsrecordedinaccountspayableandaccruedexpenses	2301000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities at the dates of the financial statements and the reported amounts of revenue and expenses during the reporting periods. On an ongoing basis, the Company evaluates its estimates, including those related to goodwill and indefinite-lived intangible assets, professional liability reserve, contingent liabilities such as legal accruals, and income taxes. The Company bases these estimates on the information that is currently available and on various other assumptions that it believes are reasonable under the circumstances. Actual results could differ from those estimates under different assumptions or conditions.
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	180928000	USD
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	29213000	USD
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	29262000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18626000	USD
CY2021Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	64482000	USD
CY2020Q4	us-gaap	Restricted Cash And Investments Noncurrent RestrictedCashAndInvestmentsNoncurrent	61347000	USD
CY2021Q4	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	274672000	USD
CY2020Q4	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	109186000	USD
CY2021Q4	us-gaap	Restricted Investments RestrictedInvestments	27958000	USD
CY2020Q4	us-gaap	Restricted Investments RestrictedInvestments	25196000	USD
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	246714000	USD
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	83990000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	10660000	USD
CY2020	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	11729000	USD
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	3332000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1206000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7043000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	4428000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1411000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	2051000	USD
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	6838000	USD
CY2020Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	7043000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	Concentration of Credit Risk The majority of the Company’s business activity is with hospitals located throughout the United States. Credit is extended based on the evaluation of each entity’s financial condition. The Company’s cash and cash equivalents and restricted cash, cash equivalents and investments accounts are financial instruments that are exposed to concentration of credit risk. The Company maintains most of its cash, cash equivalents and investment balances with high-credit quality and federally insured institutions. However, cash equivalents and restricted cash equivalents and investment balances may be invested in non-federally insured money market funds, commercial paper and corporate bonds.
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47424000	shares
CY2021Q4	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	274672000	USD
CY2020Q4	amn	Total Cash Cash Equivalents And Restricted Cash Cash Equivalentsand Investments TotalCashCashEquivalentsAndRestrictedCashCashEquivalentsandInvestments	109186000	USD
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	33000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	41000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	43000	shares
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	327388000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	327388000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	70665000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	70665000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	113988000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	113988000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	6.87
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.49
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.44
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	6.81
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.48
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.40
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47685000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46704000	shares
CY2021	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	360000	shares
CY2020	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	266000	shares
CY2019	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	889000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48045000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47690000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47593000	shares
CY2019	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	3	segment
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	101152000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	92766000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	58520000	USD
CY2021	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	2545000	USD
CY2020	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	1421000	USD
CY2019	amn	Depreciation Included In Revenue DepreciationIncludedInRevenue	0	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	25217000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	20465000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	16241000	USD
CY2021	us-gaap	Interest Expense InterestExpense	34077000	USD
CY2020	us-gaap	Interest Expense InterestExpense	57742000	USD
CY2019	us-gaap	Interest Expense InterestExpense	28427000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	443921000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	91523000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	148488000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	3984235000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2393714000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2222107000	USD
	us-gaap	Number Of Businesses Acquired NumberOfBusinessesAcquired	5	acquisition
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	5528000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	22430000	USD
CY2021Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	27958000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	792709000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	278249000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	514460000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	690745000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	215234000	USD
CY2020Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	475511000	USD
CY2020Q4	us-gaap	Goodwill Goodwill	864485000	USD
CY2020	amn	Goodwill Change In Goodwill Allocation GoodwillChangeInGoodwillAllocation	0	USD
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	514460000	USD
CY2020Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	564911000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	63015000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	63817000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	79001000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	77333000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	70783000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	57772000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	48050000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	181521000	USD
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	514460000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2019Q4	us-gaap	Goodwill Goodwill	595551000	USD
CY2021Q4	us-gaap	Goodwill Goodwill	892341000	USD
CY2020Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	USD
CY2021Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	214939000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Renewal Term LesseeOperatingLeaseRenewalTerm	P10Y
CY2021	amn	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P2Y
CY2021Q3	amn	Number Of Phases Of Lease Termination Agreement NumberOfPhasesOfLeaseTerminationAgreement	2	phase
CY2021Q3	amn	Payments Of Lease Termination Fee PaymentsOfLeaseTerminationFee	17000000	USD
CY2021Q3	amn	Operating Lease Liability Increase Decrease From Modification OperatingLeaseLiabilityIncreaseDecreaseFromModification	-27340000	USD
CY2021Q3	amn	Operating Lease Right Of Use Asset Increase Decrease From Modification OperatingLeaseRightOfUseAssetIncreaseDecreaseFromModification	-27340000	USD
CY2021Q3	amn	Lessee Operating Lease Liability To Be Paid Premodification LesseeOperatingLeaseLiabilityToBePaidPremodification	62487000	USD
CY2021Q3	amn	Lessee Operating Lease Liability To Be Paid Postmodification LesseeOperatingLeaseLiabilityToBePaidPostmodification	9564000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	23495000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	5348000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	20176000	USD
CY2019	us-gaap	Operating Lease Cost OperatingLeaseCost	18725000	USD
CY2021	us-gaap	Short Term Lease Cost ShortTermLeaseCost	6056000	USD
CY2020	us-gaap	Short Term Lease Cost ShortTermLeaseCost	8702000	USD
CY2019	us-gaap	Short Term Lease Cost ShortTermLeaseCost	20112000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	2485000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	2526000	USD
CY2019	us-gaap	Variable Lease Cost VariableLeaseCost	2880000	USD
CY2021	us-gaap	Lease Cost LeaseCost	32036000	USD
CY2020	us-gaap	Lease Cost LeaseCost	31404000	USD
CY2019	us-gaap	Lease Cost LeaseCost	41717000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	11867000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	6468000	USD
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	24747000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	39865000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	20052000	USD
CY2019	us-gaap	Operating Lease Payments OperatingLeasePayments	17817000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1876000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	112000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	25671000	USD
CY2021Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	924000	USD
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y
CY2020Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y
CY2021Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.026
CY2020Q4	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.048
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	29262000	USD
CY2020Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	18626000	USD
CY2021Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	37568000	USD
CY2020Q4	us-gaap	Other Assets Miscellaneous Current OtherAssetsMiscellaneousCurrent	22183000	USD
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	66830000	USD
CY2020Q4	us-gaap	Other Assets Current OtherAssetsCurrent	40809000	USD
CY2021Q4	amn	Prepaid Payroll Deposits PrepaidPayrollDeposits	60014000	USD
CY2020Q4	amn	Prepaid Payroll Deposits PrepaidPayrollDeposits	0	USD
CY2021Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	12446000	USD
CY2020Q4	us-gaap	Other Prepaid Expense Current OtherPrepaidExpenseCurrent	13629000	USD
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	72460000	USD
CY2020Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	13629000	USD
CY2021Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	43134000	USD
CY2020Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	47355000	USD
CY2021Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	265137000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	116174000	USD
CY2020Q4	us-gaap	Capitalized Computer Software Gross CapitalizedComputerSoftwareGross	220971000	USD
CY2021Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	8797000	USD
CY2020Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	9600000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	317068000	USD
CY2020Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	277926000	USD
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	189954000	USD
CY2020Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	161752000	USD
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	127114000	USD
CY2021Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	77325000	USD
CY2020Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	28089000	USD
CY2021Q4	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	261689000	USD
CY2020Q4	amn	Accounts Payable To Subcontractor AccountsPayableToSubcontractor	79364000	USD
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	61220000	USD
CY2020Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37849000	USD
CY2021Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	10400000	USD
CY2020Q4	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	7613000	USD
CY2021Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	7127000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Current SelfInsuranceReserveCurrent	8897000	USD
CY2021Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	7496000	USD
CY2020Q4	us-gaap	Other Accounts Payable And Accrued Liabilities OtherAccountsPayableAndAccruedLiabilities	6069000	USD
CY2021Q4	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	425257000	USD
CY2020Q4	amn	Accounts Payable And Accrued Expenses Excluding Accrued Compensation And Benefits Current AccountsPayableAndAccruedExpensesExcludingAccruedCompensationAndBenefitsCurrent	167881000	USD
CY2021Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	98817000	USD
CY2020Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	59721000	USD
CY2021Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	105155000	USD
CY2020Q4	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	34514000	USD
CY2021Q4	amn	Accrued Travel Expense AccruedTravelExpense	3058000	USD
CY2020Q4	amn	Accrued Travel Expense AccruedTravelExpense	1998000	USD
CY2021Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	6041000	USD
CY2020Q4	us-gaap	Accrued Insurance Current AccruedInsuranceCurrent	5590000	USD
CY2021Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	12384000	USD
CY2020Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	213414000	USD
CY2020Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	4163000	USD
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	354381000	USD
CY2020Q4	us-gaap	Workers Compensation Liability Current WorkersCompensationLiabilityCurrent	10244000	USD
CY2021Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	119617000	USD
CY2020Q4	us-gaap	Deferred Compensation Liability Current DeferredCompensationLiabilityCurrent	97184000	USD
CY2021Q4	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	9309000	USD
CY2021Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	21162000	USD
CY2020Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2021Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	0	USD
CY2020Q4	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	8000000	USD
CY2021Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	141102000	USD
CY2020Q4	us-gaap	Deposit Liability Current DepositLiabilityCurrent	1636000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	155000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Current OtherSundryLiabilitiesCurrent	1302000	USD
CY2021Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	162419000	USD
CY2020Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	10938000	USD
CY2021Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	24130000	USD
CY2020Q4	us-gaap	Workers Compensation Liability Noncurrent WorkersCompensationLiabilityNoncurrent	20930000	USD
CY2021Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	34544000	USD
CY2020Q4	us-gaap	Self Insurance Reserve Noncurrent SelfInsuranceReserveNoncurrent	31997000	USD
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	4633000	USD
CY2020Q4	us-gaap	Liability For Uncertain Tax Positions Noncurrent LiabilityForUncertainTaxPositionsNoncurrent	5447000	USD
CY2021Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	33682000	USD
CY2020Q4	us-gaap	Other Sundry Liabilities Noncurrent OtherSundryLiabilitiesNoncurrent	49533000	USD
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	96989000	USD
CY2020Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	107907000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	98795000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	32673000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	25255000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	34025000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	9813000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	8332000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	132820000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	42486000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	33587000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-12992000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-15092000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	625000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-3295000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-6536000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	288000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-16287000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-21628000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	913000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	116533000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20858000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34500000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	93223000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	19220000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	31253000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	23990000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	4161000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	6810000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	0	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	3621000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Meals And Entertainment IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment	3840000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1460000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-3755000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-2426000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2311000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-4770000	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-680000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-78000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Contingencies IncomeTaxReconciliationTaxContingencies	-207000	USD
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1460000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	116533000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20858000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	34500000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6954000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	6198000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	30513000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	24604000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	24636000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Bonuses DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBonuses	7607000	USD
CY2021Q4	amn	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Payroll Taxes DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPayrollTaxes	6427000	USD
CY2020Q4	amn	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Payroll Taxes DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsPayrollTaxes	12445000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	19899000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Accrued Liabilities DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities	13371000	USD
CY2021Q4	amn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	6472000	USD
CY2020Q4	amn	Deferred Tax Assets Operating Lease Liabilities DeferredTaxAssetsOperatingLeaseLiabilities	23826000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8815000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	9557000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	8528000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves	6459000	USD
CY2021Q4	amn	Deferred Tax Assets Workers Compensation Insurance DeferredTaxAssetsWorkersCompensationInsurance	6476000	USD
CY2020Q4	amn	Deferred Tax Assets Workers Compensation Insurance DeferredTaxAssetsWorkersCompensationInsurance	4814000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2731000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	989000	USD
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	121451000	USD
CY2020Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	109870000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	126535000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets	126833000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	28824000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	25252000	USD
CY2021Q4	amn	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	7269000	USD
CY2020Q4	amn	Deferred Tax Liabilities Operating Lease Right Of Use Assets DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets	19933000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	6637000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	5057000	USD
CY2021Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	169265000	USD
CY2020Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	177075000	USD
CY2021Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	47814000	USD
CY2020Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	67205000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4916000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4937000	USD
CY2018Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4393000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	504000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	667000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	588000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	255000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	990000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	301000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1052000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	943000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations	1034000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4067000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4916000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4937000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	3936000	USD
CY2021Q4	amn	Unrecognized Tax Benefits That Would Impact Effective Tax Rate Temporary Differences UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRateTemporaryDifferences	697000	USD
CY2021Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	564000	USD
CY2020Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	530000	USD
CY2019Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	493000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	34000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	37000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense	26000	USD
CY2021Q4	amn	Deferred Payroll Taxes Cares Act DeferredPayrollTaxesCARESAct	48452000	USD
CY2021Q4	amn	Employee Retention Employment Tax Credit Cares Act EmployeeRetentionEmploymentTaxCreditCARESAct	1756000	USD
CY2019	amn	Defined Contribution Plan Employer Discretionary Contribution Amount Net Of Forfeitures DefinedContributionPlanEmployerDiscretionaryContributionAmountNetOfForfeitures	5516000	USD
CY2021Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	850000000	USD
CY2020Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	871875000	USD
CY2021Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	7678000	USD
CY2020Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	9226000	USD
CY2021Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	0	USD
CY2020Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	4688000	USD
CY2021Q4	us-gaap	Long Term Debt LongTermDebt	842322000	USD
CY2020Q4	us-gaap	Long Term Debt LongTermDebt	857961000	USD
CY2021	amn	Defined Contribution Plan Employer Discretionary Contribution Amount Net Of Forfeitures DefinedContributionPlanEmployerDiscretionaryContributionAmountNetOfForfeitures	13157000	USD
CY2020	amn	Defined Contribution Plan Employer Discretionary Contribution Amount Net Of Forfeitures DefinedContributionPlanEmployerDiscretionaryContributionAmountNetOfForfeitures	4256000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	818000	shares
CY2021Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	115095000	USD
CY2020Q4	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	98161000	USD
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2020Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	150000000	USD
CY2021Q4	amn	Stock Repurchase Program Additional Authorized Amount StockRepurchaseProgramAdditionalAuthorizedAmount	150000000	USD
CY2021	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	25000	shares
CY2021	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	108.97
CY2021	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	2688000	USD
CY2020	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	0	shares
CY2019	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	395000	shares
CY2019	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	47.30
CY2019	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	18705000	USD
CY2018Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	43.84
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	400000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	35.46
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	52000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	41.09
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	758000	shares
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	52.45
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	283000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	49.18
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	184000	shares
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	53.84
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	717000	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	58.88
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	280000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	56.05
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	158000	shares
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	20465000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	65.69
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	755000	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	78.13
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	25217000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	16241000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	6556000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5321000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	4223000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	18661000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	15144000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	12018000	USD

Files In Submission

Name	View Source	Status
0001142750-22-000010-index-headers.html	Edgar Link	pending
0001142750-22-000010-index.html	Edgar Link	pending
0001142750-22-000010.txt	Edgar Link	pending
0001142750-22-000010-xbrl.zip	Edgar Link	pending
amn-20211231.htm	Edgar Link	pending
amn-20211231.xsd	Edgar Link	pending
amn-20211231_cal.xml	Edgar Link	unprocessable
amn-20211231_def.xml	Edgar Link	unprocessable
amn-20211231_g1.jpg	Edgar Link	pending
amn-20211231_g2.jpg	Edgar Link	pending
amn-20211231_htm.xml	Edgar Link	completed
amn-20211231_lab.xml	Edgar Link	unprocessable
amn-20211231_pre.xml	Edgar Link	unprocessable
amn-ex105x20211231x10k.htm	Edgar Link	pending
amn-ex106x20211231x10k.htm	Edgar Link	pending
amn-ex109x20211231x10k.htm	Edgar Link	pending
amn-ex211x20211231x10k.htm	Edgar Link	pending
amn-ex231x20211231x10k.htm	Edgar Link	pending
amn-ex311x20211231x10k.htm	Edgar Link	pending
amn-ex312x20211231x10k.htm	Edgar Link	pending
amn-ex321x20211231x10k.htm	Edgar Link	pending
amn-ex322x20211231x10k.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
image_7a.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn

2021 Q4 Form 10-K Financial Statement

#000114275022000010 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN AMN HEALTHCARE SERVICES INC Stock $amn

2021 Q4 Form 10-K Financial Statement

#000114275022000010 Filed on February 24, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$AMN
AMN HEALTHCARE SERVICES INC Stock $amn